CRIS Current Research Information System

MARTIGNANI, CRISTIAN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.465
EU - Europa 8.633
AS - Asia 7.868
AF - Africa 564
SA - Sud America 475
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 5
Totale 27.029
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.394
SG - Singapore 2.407
GB - Regno Unito 2.186
CN - Cina 2.053
IT - Italia 1.982
VN - Vietnam 1.913
DE - Germania 1.136
UA - Ucraina 710
SE - Svezia 672
HK - Hong Kong 595
RU - Federazione Russa 495
IN - India 434
FR - Francia 390
BR - Brasile 341
IE - Irlanda 275
NL - Olanda 193
CI - Costa d'Avorio 190
EE - Estonia 178
JP - Giappone 146
ZA - Sudafrica 146
KR - Corea 143
FI - Finlandia 125
TG - Togo 85
SC - Seychelles 72
AR - Argentina 70
CH - Svizzera 61
BG - Bulgaria 57
JO - Giordania 49
NG - Nigeria 38
CA - Canada 36
BE - Belgio 34
IR - Iran 31
MX - Messico 27
AT - Austria 26
ID - Indonesia 22
PL - Polonia 22
GR - Grecia 20
BD - Bangladesh 19
EC - Ecuador 18
AU - Australia 17
RO - Romania 15
ES - Italia 13
CL - Cile 12
IQ - Iraq 12
CO - Colombia 11
EG - Egitto 11
PY - Paraguay 10
TR - Turchia 9
LT - Lituania 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
MA - Marocco 6
LB - Libano 5
PE - Perù 5
UZ - Uzbekistan 5
KZ - Kazakistan 4
NO - Norvegia 4
RS - Serbia 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
EU - Europa 3
HU - Ungheria 3
LU - Lussemburgo 3
MY - Malesia 3
PK - Pakistan 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
DK - Danimarca 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
PT - Portogallo 2
SN - Senegal 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BZ - Belize 1
CM - Camerun 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
HT - Haiti 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
Totale 27.028
Salva come PNG Salva come JPEG
Città #
Southend 1.919
Singapore 1.572
Ashburn 1.007
Fairfield 954
Chandler 632
Hong Kong 593
Jacksonville 523
Wilmington 494
Santa Clara 483
Seattle 450
Dong Ket 449
Woodbridge 444
Princeton 442
Houston 421
Hefei 343
Cambridge 310
Beijing 297
Ann Arbor 285
Dublin 275
Boardman 262
Ho Chi Minh City 229
Westminster 201
Padova 200
Nanjing 193
Abidjan 190
Hanoi 186
Milan 161
Bologna 153
Los Angeles 146
Tokyo 146
Seoul 129
Berlin 122
Saint Petersburg 112
Rome 105
Helsinki 103
Buffalo 101
Medford 100
Shenyang 100
New York 97
Jinan 93
Bremen 92
Lomé 85
Mülheim 82
Changsha 77
Turin 74
Dallas 70
San Diego 68
Mahé 67
Nanchang 62
Sofia 57
Munich 54
Hebei 53
Amman 49
Redondo Beach 48
Bern 43
Des Moines 43
Olalla 43
Guangzhou 42
Jiaxing 42
Abeokuta 38
Tianjin 37
Frankfurt am Main 36
Verona 35
Bari 34
São Paulo 34
Zhengzhou 34
Bengaluru 33
Brussels 33
Ningbo 31
Hangzhou 30
Naples 30
Chicago 29
Shanghai 28
Yubileyny 27
Falkenstein 25
Norwalk 23
Haikou 22
Mountain View 22
Dearborn 21
Florence 21
London 21
Taizhou 21
Haiphong 20
Düsseldorf 19
Lanzhou 19
Phoenix 19
Brooklyn 18
Falls Church 18
Da Nang 17
Biên Hòa 16
Hải Dương 16
Warsaw 16
Bühl 15
Chengdu 15
Monmouth Junction 15
Rio de Janeiro 15
Toronto 15
Monterotondo 14
Paris 14
Pune 14
Totale 17.133
Salva come PNG Salva come JPEG
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.018
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 267
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 251
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 225
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 221
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 211
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 209
Aritimie cardiache, morte cardiaca improvvisa, sincope 198
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 197
Bridging the future of cardiac stimulation: physiologic or leadless pacing? 193
AF burden is important - Fact or fiction? 192
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 188
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 187
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 186
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 185
Electrocardiographic remodeling during cardiac resynchronization therapy 182
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 182
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 174
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 174
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 172
Atrial fibrillation ablation: beyond electro-mechanical matters 169
Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study 164
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 164
Rate control in AFFIRM: considerations about the clinical implications. 163
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 163
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 160
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 159
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 159
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 158
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 158
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 157
Pacing with capture verification in candidates for resynchronisation therapy: a feasibility study. 156
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 154
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 154
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 154
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 152
Implantation of cardioverter-defibrillator: Effects on shoulder function. 151
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 150
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 150
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 149
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 149
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 148
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 148
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 147
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 147
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 146
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 145
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 145
Atrial fibrillation and heart failure: does one epidemic feed he other? 145
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. 143
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 143
Cardiac resynchronization therapy : effects on left and right ventricular ejection fraction during exercise 143
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 141
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 141
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 140
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker. 140
Is ventricular sensing always right, when it is left? 139
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices 138
Decrease in patient radiation exposure by a tantalum filter during electrophysiological procedures. 137
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 136
Poor Glycaemic Control and Arrhythmias. 135
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 135
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 135
Predictors of long-term survival free from relapses after extraction of infected CIED. 135
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 135
Effetti emodinamici del pacing biventricolare a distanza di un anno dall'impianto 133
Cardiac resynchronisation therapy: effect on diastolic function –Evaluation by radionuclide angiography 133
Long-Term Atrioventricular Block Following Valve Surgery: Electrocardiographic and Surgical Predictors 132
Biventricular pacing in heart failure: what relationship between electrocardiographic and structural remodeling? 131
Expenditure and value for money: the challenge of implantable cardioverter defibrillators 130
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 130
Atrial fibrillation: Adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction. 130
Role of drugs and devices in patients at risk of sudden cardiac death. 130
The QRS interval in patients treated with resynchronization therapy: which value 129
Phrenic stimulation: a challenge for cardiac resynchronization therapy 129
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. 129
Cardiac resynchronization by pacing: an electrical treatment of heart failure 129
Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death 128
La fibrillazione atriale e il controllo della frequenza ventricolare: approccio terapeutico e valutazione dell’efficacia del trattamento 127
La cardioversione elettrica nella pratica clinica:quali predittori di efficacia della procedura e di recidiva di fibrillazione/flutter atriale a lungo termine? 127
Cardiac resynchronization therapy and VV interval optimization: which relationship between QRS width and the results of echo-guided VV interval optimization? 127
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 127
Peri-operative management of patients taking antithrombotic therapy: need for an integrated proactive approach. 127
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 126
A plateau waveform shape allows a much higher patient shock energy tolerance 126
Atrial fibrillation in patients with a dual defibrillator: characteristics of spontaneous and induced episodes and effect of ventricular tachyarrhythmia induction. 126
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy. 126
Cardioversione elettrica di fibrillazione e flutter atriale: risultati a distanza. 125
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia 125
Risultati a lungo termine della cardioversione elettrica di fibrillazione o flutter atriale. 124
Is cardiac resynchronization therapy cost-effective? 124
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 123
Cardiac resynchronization therapy: a cost or an investment? 123
Atrial fibrillation in patients with cardiac resynchronization therapy: Clinical management and outcome 123
Risultati e complicanze dell'impianto di cardioverter-defibrillatore in pazienti con cardiomiopatia aritmogena del ventricolo destro. 122
Cardiac resynchronisation therapy: effect on intra-ventricular and inter-ventricular dyssynchrony at radionuclide angiography by Fourier phase analysis 122
Cardiac resynchronization therapy: update on clinical studies 121
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry 120
Cardioversione elettrica di fibrillazione atriale associata ad impianto di dispositivo per la resincronizzazione cardiaca: quali i risulatati a lungo termine? 120
Il follow up di pace maker e defibrillatori: Valutazione degli attuali disagi per i pazienti e del potenziale impatto di sistemi di controllo remoto mediante telemedicina. Abstract 69° Congresso Nazionale Società Italiana di Cardiologia 120
Totale 15.916
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.289
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.144 0 0 0 0 0 140 35 160 217 155 134 1.303
2021/20223.403 334 173 219 292 326 228 48 271 104 154 607 647
2022/20233.769 365 452 189 501 217 221 115 196 666 218 319 310
2023/20241.162 93 178 88 79 119 228 83 75 62 58 40 59
2024/20254.275 189 797 318 312 801 196 189 111 56 268 177 861
2025/20264.691 887 854 949 678 1.005 318 0 0 0 0 0 0
Totale 27.447